TY - JOUR
T1 - Drug consumption in the first years of rheumatoid arthritis in France, the Netherlands, and Norway
T2 - A longitudinal study in the early nineties
AU - Ludig, A
AU - Guillemin, F
AU - Chary-Valckenaere, Isabelle
AU - Suurmeijer, Theo P B M
AU - Moum, T
AU - van den Heuvel, Wim J A
N1 - Relation: http://www.rug.nl/
date_submitted:2006
Rights: University of Groningen
PY - 2000
Y1 - 2000
N2 - Objective: To analyse drug consumption in the first years of rheumatoid arthritis (RA) in France, the Netherlands, and Norway, in a longitudinal study between 1991 and 1993.Patients and Methods: The EURIDISS cohort followed up over three years included 695 RA subjects with less than 5 years disease duration. Clinical and biological parameters, drug consumption according to ATC classification, and use of local treatment were recorded.Results: In the Netherlands consumption of second-line treatment occurred early on, and remained constant over time. Tn France, it was consumed by half of the subjects and decreased during follow-up (p <0.001). In Norway, 50% of the subjects were on second-line treatment at the outset. NSAIDs rather than corticoids were the most widely consumed. Patients underwent frequently local treatments with decrease frequency of infiltrations over time (pConclusion: Second-line treatments were used in the first years of disease development, following varying sequences in the different countries.
AB - Objective: To analyse drug consumption in the first years of rheumatoid arthritis (RA) in France, the Netherlands, and Norway, in a longitudinal study between 1991 and 1993.Patients and Methods: The EURIDISS cohort followed up over three years included 695 RA subjects with less than 5 years disease duration. Clinical and biological parameters, drug consumption according to ATC classification, and use of local treatment were recorded.Results: In the Netherlands consumption of second-line treatment occurred early on, and remained constant over time. Tn France, it was consumed by half of the subjects and decreased during follow-up (p <0.001). In Norway, 50% of the subjects were on second-line treatment at the outset. NSAIDs rather than corticoids were the most widely consumed. Patients underwent frequently local treatments with decrease frequency of infiltrations over time (pConclusion: Second-line treatments were used in the first years of disease development, following varying sequences in the different countries.
KW - rheumatoid arthritis
KW - treatment
KW - consumption
KW - drugs
KW - METHOTREXATE
KW - DISABILITY
KW - DISEASES
KW - REGISTER
KW - THERAPY
U2 - 10.1080/030097400447543
DO - 10.1080/030097400447543
M3 - Article
VL - 29
SP - 352
EP - 357
JO - Scandinavian Journal of Rheumatology
JF - Scandinavian Journal of Rheumatology
IS - 6
ER -